A new trading day began on Monday, with Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) stock price down -8.93% from the previous day of trading, before settling in for the closing price of $37.98. TNXP’s price has ranged from $6.76 to $130.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 73.03%. Meanwhile, its annual earnings per share averaged 92.65%. With a float of $8.76 million, this company’s outstanding shares have now reached $8.77 million.
Considering the fact that the conglomerate employs 81 people, you should pay attention to its efficiency factor.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.08%, while institutional ownership is 16.09%. The most recent insider transaction that took place on Aug 21 ’25, was worth 15,061. In this transaction Director of this company bought 418 shares at a rate of $36.03, taking the stock ownership to the 418 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Director bought 250 for $36.00, making the entire transaction worth $9,000. This insider now owns 250 shares in total.
Tonix Pharmaceuticals Holding Corp (TNXP) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -25.56 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 92.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 88.07% during the next five years compared to 73.03% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Here are Tonix Pharmaceuticals Holding Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 30.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1006.28, a number that is poised to hit -3.31 in the next quarter and is forecasted to reach -8.61 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Compared to the last year’s volume of 1.4 million, its volume of 1.63 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 5.95%.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 36.55%, which indicates a significant increase from 1.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 6.29 in the past 14 days, which was higher than the 3.51 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.42, while its 200-day Moving Average is $27.39. Nevertheless, the first resistance level for the watch stands at $36.63 in the near term. At $38.66, the stock is likely to face the second major resistance level. The third major resistance level sits at $39.77. If the price goes on to break the first support level at $33.49, it is likely to go to the next support level at $32.38. Should the price break the second support level, the third support level stands at $30.35.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
With a market capitalization of 303.35 million, the company has a total of 8,766K Shares Outstanding. Currently, annual sales are 10,090 K while annual income is -130,040 K. The company’s previous quarter sales were 2,000 K while its latest quarter income was -28,270 K.
